The global clinical trial kits market is undergoing a significant transformation, driven by advancements in decentralized trials, technological innovations, and growing demand for personalized medicine. Valued at USD 1.42 billion in 2021, the market is projected to reach well beyond USD 2.8 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 8.3% during the...